Australian agri-biotech company Nbryo has completed a $10m capital raising to accelerate genetic improvement in the global ...
Tom Brady reveals his new dog Junie is a clone of his late pet Lua, sparking debate on the science, ethics and high cost of ...
Although heart cells and skin cells contain identical instructions for creating proteins encoded in their DNA, they're able ...
Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...
Colossal’s purchase of ViaGen, known for cloning pets of celebrities, bolsters the biotech firm’s tools for de-extinction and ...
The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...
The Southern Maryland Chronicle on MSN
New Era for Maryland Kids’ Health with $50M Pledge
Philanthropist Tom Golisano donated $50 million to the University of Maryland Children’s Hospital on October 28, 2025, ...
Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...
Colossal Biosciences, which has brought to life a small pack of genetically modified dire wolves, has acquired cloning ...
Colossal Biosciences, the world's de-extinction company, today announced its acquisition of Viagen Pets and Equine, the global leader and expert in animal cloning. Viagen provides genetic preservation ...
In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...
TSHA-102 granted Breakthrough Therapy designation by FDAFinalized FDA alignment on REVEAL pivotal trial protocol and SAP, including 6-month ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback